Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>
Strong International Growth and Order Book: UEM Edgenta is successfully executing a strategy of international expansion, with over 90% of new contracts in 1H 2024 originating from Singapore, Taiwan, and the Middle East. This has bolstered its total order book to RM9.3 billion as of March 2025, providing significant revenue visibility.</li>
 <li>
Resilient Business Model Amidst Margin Pressures: Despite recent quarterly losses attributed to higher operational costs and cyclical factors, the company demonstrates resilience through its diversified service offerings and long-term contracts, particularly in the essential healthcare and infrastructure sectors. Management expects a return to profitability driven by new contract contributions and cost management initiatives.</li>
 <li>
Attractive Valuation with Turnaround Potential: The company trades at a significant discount to peers on key metrics like EV/Sales and EV/EBITDA. While recent earnings volatility is a concern, the combination of a robust order book, a strategic focus on technology and international growth, and a formal cost-saving program presents a compelling turnaround narrative.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Strong International Growth and Order Book: UEM Edgenta is successfully executing a strategy of international expansion, with over 90% of new contracts in 1H 2024 originating from Singapore, Taiwan, and the Middle East. This has bolstered its total order book to RM9.3 billion as of March 2025, providing significant revenue visibility.
  
Resilient Business Model Amidst Margin Pressures: Despite recent quarterly losses attributed to higher operational costs and cyclical factors, the company demonstrates resilience through its diversified service offerings and long-term contracts, particularly in the essential healthcare and infrastructure sectors. Management expects a return to profitability driven by new contract contributions and cost management initiatives.
  
Attractive Valuation with Turnaround Potential: The company trades at a significant discount to peers on key metrics like EV/Sales and EV/EBITDA. While recent earnings volatility is a concern, the combination of a robust order book, a strategic focus on technology and international growth, and a formal cost-saving program presents a compelling turnaround narrative.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: UEM Edgenta Bhd (UEME MK) - Dec 2025

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

Broadly speaking, RS for MSCI EM is currently exhibiting some mild deterioration vs. MSCI EAFE following four months of clear outperformance. Nonetheless, the MSCI EM index is bottoming and remains attractive from a price perspective.  In today's report we offer a technical appraisal of major EM markets, and offer a host of technically attractivec bottoms-up stock ideas across the EM universe.

Broadly speaking, RS for MSCI EM is currently exhibiting some mild deterioration vs. MSCI EAFE following four months of clear outperformance. Nonetheless, the MSCI EM index is bottoming and remains attractive from a price perspective.  In today's report we offer a technical appraisal of major EM markets, and offer a host of technically attractivec bottoms-up stock ideas across the EM universe.

EM Equity Strategy: Cyclicals Leading, China Surging

Malaysia

UEM Edgenta Berhad is an investment holding company which provides management services. Through its subsidiaries, the Company provides hospital support services, hotel management services, develops hotels, and operates as a hotel proprietor. UEM also develops and manages properties.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

UEM Edgenta Bhd (UEME MK)

Primer: UEM Edgenta Bhd (UEME MK) - Dec 2025

Strong International Growth and Order Book: UEM Edgenta is successfully executing a strategy of international expansion, with over 90% of new...

αSK

EM Equity Strategy: Cyclicals Leading, China Surging

Broadly speaking, RS for MSCI EM is currently exhibiting some mild deterioration vs. MSCI EAFE following four months of clear outperformance....

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)